Physician profile
Alene Mcneese
NPI 1184231235
$976.54
in general payments reported to CMS, 2019-2025
19 companies · $548 in 2025
The $548 reported for 2025 was more than what 93% of Pediatrics, Critical Care providers received nationally (typical 2025 total: $80.91).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.30 · 2022: $143 · 2023: $41.58 · 2024: $227 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $817.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $159.35 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $115.74 | 2024 | |
| Genmab U.S., INC. | $88.82 | 2025 | Epkinly |
| Springworks Therapeutics, INC. | $77.60 | 2025 | Gomekli |
| Takeda Pharmaceuticals U.S.A., INC. | $69.46 | 2024-2025 | Livtencity |
| Pfizer INC. | $67.28 | 2025 | |
| Mesoblast, INC. | $60.76 | 2025 | Ryoncil |
| Sobi, INC | $47.05 | 2025 | |
| Novartis Pharmaceuticals Corporation | $34.39 | 2023-2024 | |
| Csl Behring | $29.19 | 2024 | Hemgenix |
| Sanofi-Aventis U.S. LLC | $29.15 | 2025 | |
| Alcresta Therapeutics, INC. | $29.08 | 2025 | Relizorb |
| Y-Mabs Therapeutics, INC. | $28.19 | 2025 | Danyelza |
| Amgen INC. | $25.62 | 2023 | Blincyto |
| Upsher-Smith Laboratories LLC | $25.00 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uswm, LLC | $23.81 | 2025 | Iwilfin |
| Genzyme Corporation | $23.30 | 2024 | |
| Celgene Corporation | $22.86 | 2024 | |
| Syndax Pharmaceuticals, INC. | $19.89 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alene Mcneese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.